Progesterone receptor modulators for use in the therapy of uterine fibroids
US10172869B2 · kind B2 · utility
0Cited by
15References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 9, 2014 |
| Grant date | Jan 8, 2019 |
| Priority date | — |
| Expiry date | Apr 9, 2034 |
Classification
- Technology area (CPC H)Electricity
- CPC primaryH05K9/0052
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a long-term therapy including repeated treatment courses of ulipristal acetate or any metabolite thereof for treating uterine fibroids. The present invention also relates to a combined therapy applying ulipristal acetate with a progestin in order to improve the currently used treatment for uterine fibroids.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.